These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25775665)

  • 1. PCQoL: A Quality of Life Assessment Measure for Pachyonychia Congenita.
    Abbas M; Schwartz ME; Smith FJ; McLean WH; Hull PR
    J Cutan Med Surg; 2015; 19(1):57-65. PubMed ID: 25775665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma.
    Koren A; Sprecher E; Reider E; Artzi O
    Br J Dermatol; 2020 Mar; 182(3):671-677. PubMed ID: 31127950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pachyonychia congenita in pediatric patients: natural history, features, and impact.
    Shah S; Boen M; Kenner-Bell B; Schwartz M; Rademaker A; Paller AS
    JAMA Dermatol; 2014 Feb; 150(2):146-53. PubMed ID: 24132595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation study of Sinhala version of the dermatology life quality index (DLQI).
    Madarasingha NP; de Silva P; Satgurunathan K
    Ceylon Med J; 2011 Mar; 56(1):18-22. PubMed ID: 21542429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questionnaire Modifications and Alternative Scoring Methods of the Dermatology Life Quality Index: A Systematic Review.
    Rencz F; Szabó Á; Brodszky V
    Value Health; 2021 Aug; 24(8):1158-1171. PubMed ID: 34372982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
    Samuelov L; Smith FJD; Hansen CD; Sprecher E
    Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chinese version of the Perceived Stress Questionnaire: development and validation amongst medical students and workers.
    Meng R; Li J; Wang Z; Zhang D; Liu B; Luo Y; Hu Y; Yu C
    Health Qual Life Outcomes; 2020 Mar; 18(1):70. PubMed ID: 32169070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Contact Lens Impact on Quality of Life (CLIQ) Questionnaire: development and validation.
    Pesudovs K; Garamendi E; Elliott DB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2789-96. PubMed ID: 16799015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Rasch analysis and test-retest reliability.
    Rifbjerg-Madsen S; Wæhrens EE; Danneskiold-Samsøe B; Amris K
    Health Qual Life Outcomes; 2017 May; 15(1):110. PubMed ID: 28532452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical Test Theory versus Rasch analysis for quality of life questionnaire reduction.
    Prieto L; Alonso J; Lamarca R
    Health Qual Life Outcomes; 2003 Jul; 1():27. PubMed ID: 12952544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Rasch rating scale model to reassess the psychometric properties of the Persian version of the PedsQL™ 4.0 Generic Core Scales in school children.
    Jafari P; Bagheri Z; Ayatollahi SM; Soltani Z
    Health Qual Life Outcomes; 2012 Mar; 10():27. PubMed ID: 22414135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).
    Whalley D; McKenna SP; Dewar AL; Erdman RA; Kohlmann T; Niero M; Cook SA; Crickx B; Herdman MJ; Frech F; Van Assche D
    Br J Dermatol; 2004 Feb; 150(2):274-83. PubMed ID: 14996098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of an Iranian Voice Quality of Life Profile (IVQLP) Based on a Classic and Rasch Rating Scale Model (RSM).
    Dehqan A; Yadegari F; Asgari A; Scherer RC; Dabirmoghadam P
    J Voice; 2017 Jan; 31(1):113.e19-113.e29. PubMed ID: 27342754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conceptualization, development and validation of T-QoL
    Basra MKA; Salek MS; Fenech D; Finlay AY
    Br J Dermatol; 2018 Jan; 178(1):161-175. PubMed ID: 28762236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Dutch version of the Swallowing Quality-of-Life Questionnaire (DSWAL-QoL) and the adjusted DSWAL-QoL (aDSWAL-QoL) using item analysis with the Rasch model: a pilot study.
    Simpelaere IS; Van Nuffelen G; De Bodt M; Vanderwegen J; Hansen T
    Health Qual Life Outcomes; 2017 Apr; 15(1):66. PubMed ID: 28388899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.
    McKenna SP; Cook SA; Whalley D; Doward LC; Richards HL; Griffiths CE; Van Assche D
    Br J Dermatol; 2003 Aug; 149(2):323-31. PubMed ID: 12932239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL©).
    Kamudoni P; Mueller B; Salek MS
    Qual Life Res; 2015 Apr; 24(4):1017-27. PubMed ID: 25367139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model.
    Kocher A; Ndosi M; Denhaerynck K; Simon M; Dwyer AA; Distler O; Hoeper K; Künzler-Heule P; Redmond AC; Villiger PM; Walker UA; Nicca D
    Orphanet J Rare Dis; 2021 Aug; 16(1):356. PubMed ID: 34372892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Quality of Life Impact of Refractive Correction (QIRC) Questionnaire: development and validation.
    Pesudovs K; Garamendi E; Elliott DB
    Optom Vis Sci; 2004 Oct; 81(10):769-77. PubMed ID: 15557851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory.
    Wu J; Hu L; Zhang G; Liang Q; Meng Q; Wan C
    Qual Life Res; 2016 Aug; 25(8):2087-100. PubMed ID: 26928910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.